UPDATE: Pfizer options trade approaches target —#SaxoStrats
We introduced on June 1 a call option trade on shares of NYSE-listed global biopharmaceutical company Pfizer to take advantage of a rebound.
The New York Stock Exchange biotechnology index reached a fresh high at 3,878 points yesterday, and that's helping our bullish position in drugmaker Pfizer (PFE). We are getting close to our target of $34.75 where we plan to take profits. Our single-leg call position closed at $1.67. Investors could set a stop loss at the call's purchase price of $1.10.
— Edited by John Acher
Non-independent investment research disclaimer applies. Read more
A compiled overview of Trade Views provided on TradingFloor.com is found here